scispace - formally typeset
Open AccessJournal ArticleDOI

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Reads0
Chats0
TLDR
The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies.
About
This article is published in Blood.The article was published on 2016-05-19 and is currently open access. It has received 5321 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Primary mediastinal large B-cell lymphoma

TL;DR: Molecular analysis shows PMLBCL to be a distinct entity from other DLBCL, and PET-CT scan is a powerful tool to define the real quality of response and it is hoped that future prospective trials may allow its role in the de-escalation of mediastinal RT.
Journal ArticleDOI

Update on mantle cell lymphoma.

TL;DR: The future treatment of MCL therapy will need to incorporate therapy based on risk-stratification and nonchemotherapeutic approaches, and new options will be needed at relapse.
Journal ArticleDOI

The evolution of breast implants.

TL;DR: Clinicians should strive to provide ongoing data and sound science to continue to improve clinical outcomes in the future as the evolution of breast implants with special emphasis on the advancement of the silicone implants is explored.
Journal ArticleDOI

Follicular lymphoma: 2020 update on diagnosis and management.

TL;DR: Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells that is characterized by diffuse lymphadenopathy, bone marrow involvement, and splenomegaly.
Journal ArticleDOI

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

TL;DR: TRANSFORM as mentioned in this paper is a global, phase 3 study, conducted in 47 sites in the USA, Europe, and Japan, comparing liso-cel with standard of care as second-line therapy in patients with primary refractory or early relapsed (within 12 months after response to initial therapy) LBCL.
References
More filters
Book

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

TL;DR: Thank you very much for reading who classification of tumours of haematopoietic and lymphoid tissues, and maybe you have knowledge that, people have look hundreds of times for their chosen readings like this, but end up in malicious downloads.
Journal ArticleDOI

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

TL;DR: The criteria and significance of early or precursor lesions and the identification of certain lymphoid neoplasms largely associated with particular age groups, such as children and the elderly are addressed, and the issue of borderline categories having overlapping features with large B-cell lymphomas is reviewed.
Journal ArticleDOI

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

TL;DR: The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease.
Journal ArticleDOI

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

TL;DR: MYD88 L265P is a commonly recurring mutation in patients with Waldenström's macroglobulinemia that can be useful in differentiating WaldenStröm’s macrogalobulinesia and non-IgM LPL from B-cell disorders that have some of the same features.
Related Papers (5)